Aspetti metodologici nella ricerca e caratterizzazione delle componenti monoclonali nel siero

Translated title of the contribution: Methodological issues in detection and typing of serum monoclonal components

Alberto Dolci, Arialdo Vernocchi

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Serum protein electrophoresis (SPE) is a screening test widely used in clinical practice to identify patients with monoclonal gammopathies. SPE, performed on agarose gel (AGE) or by capillary zone electrophoresis (CZE), is the only technique able to recognize a monoclonal immunoglobulin. To detect monoclonal components (MC), SPE must be visually inspected. The two available techniques show similar sensitivity for MC detection (CZE 95%, AGE 91%), with a higher specificity for AGE (99% vs. 78% for CZE). Any MC detected must be reported, because also small B-cell clones could be dangerous. Once detected, MCs need to be quantitatively measured directly on the SPE pattern by setting the limits of the corresponding peak. A concentration-related bias in MC quantitation between AGE and CZE exists. Immunotyping is the further mandatory test for confirmation and characterization of MC by either immunofixation (IFE) or immunosubtraction (ISE). In general, IFE is more sensitive than ISE, but high resolution (HRIFE) must be warranted. However, ~25% of IFE carried out on commercially available kits are difficult to interpret and thus not reportable. For identification of amyloidogenic light chain MC, sensitivity of the manual HR-IFE is 95% vs. 80% of conventional semiautomated assays. The recently introduced quantitative serum assay for immunoglobulin free light chains (FLC) is an accurate index of clonality, particularly for FLC myeloma and AL amyloidosis. To reach the highest sensitivity in MC detection a comprehensive screening panel including SPE, HR-IFE and FLC determination is recommended.

Original languageItalian
Pages (from-to)84-89
Number of pages6
JournalBiochimica Clinica
Volume36
Issue number2
Publication statusPublished - 2012

Fingerprint

Electrophoresis
Capillary Electrophoresis
Blood Proteins
Sepharose
Gels
Serum
Light
Immunoglobulin Light Chains
Paraproteinemias
Amyloidosis
Immunoglobulins
Assays
Screening
Clone cells
B-Lymphocytes
Clone Cells

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical
  • Medical Laboratory Technology

Cite this

Aspetti metodologici nella ricerca e caratterizzazione delle componenti monoclonali nel siero. / Dolci, Alberto; Vernocchi, Arialdo.

In: Biochimica Clinica, Vol. 36, No. 2, 2012, p. 84-89.

Research output: Contribution to journalArticle

@article{9fa973bef3bc42cc9123f5ab98d56f4f,
title = "Aspetti metodologici nella ricerca e caratterizzazione delle componenti monoclonali nel siero",
abstract = "Serum protein electrophoresis (SPE) is a screening test widely used in clinical practice to identify patients with monoclonal gammopathies. SPE, performed on agarose gel (AGE) or by capillary zone electrophoresis (CZE), is the only technique able to recognize a monoclonal immunoglobulin. To detect monoclonal components (MC), SPE must be visually inspected. The two available techniques show similar sensitivity for MC detection (CZE 95{\%}, AGE 91{\%}), with a higher specificity for AGE (99{\%} vs. 78{\%} for CZE). Any MC detected must be reported, because also small B-cell clones could be dangerous. Once detected, MCs need to be quantitatively measured directly on the SPE pattern by setting the limits of the corresponding peak. A concentration-related bias in MC quantitation between AGE and CZE exists. Immunotyping is the further mandatory test for confirmation and characterization of MC by either immunofixation (IFE) or immunosubtraction (ISE). In general, IFE is more sensitive than ISE, but high resolution (HRIFE) must be warranted. However, ~25{\%} of IFE carried out on commercially available kits are difficult to interpret and thus not reportable. For identification of amyloidogenic light chain MC, sensitivity of the manual HR-IFE is 95{\%} vs. 80{\%} of conventional semiautomated assays. The recently introduced quantitative serum assay for immunoglobulin free light chains (FLC) is an accurate index of clonality, particularly for FLC myeloma and AL amyloidosis. To reach the highest sensitivity in MC detection a comprehensive screening panel including SPE, HR-IFE and FLC determination is recommended.",
author = "Alberto Dolci and Arialdo Vernocchi",
year = "2012",
language = "Italian",
volume = "36",
pages = "84--89",
journal = "Biochimica Clinica",
issn = "0393-0564",
publisher = "CLAS International",
number = "2",

}

TY - JOUR

T1 - Aspetti metodologici nella ricerca e caratterizzazione delle componenti monoclonali nel siero

AU - Dolci, Alberto

AU - Vernocchi, Arialdo

PY - 2012

Y1 - 2012

N2 - Serum protein electrophoresis (SPE) is a screening test widely used in clinical practice to identify patients with monoclonal gammopathies. SPE, performed on agarose gel (AGE) or by capillary zone electrophoresis (CZE), is the only technique able to recognize a monoclonal immunoglobulin. To detect monoclonal components (MC), SPE must be visually inspected. The two available techniques show similar sensitivity for MC detection (CZE 95%, AGE 91%), with a higher specificity for AGE (99% vs. 78% for CZE). Any MC detected must be reported, because also small B-cell clones could be dangerous. Once detected, MCs need to be quantitatively measured directly on the SPE pattern by setting the limits of the corresponding peak. A concentration-related bias in MC quantitation between AGE and CZE exists. Immunotyping is the further mandatory test for confirmation and characterization of MC by either immunofixation (IFE) or immunosubtraction (ISE). In general, IFE is more sensitive than ISE, but high resolution (HRIFE) must be warranted. However, ~25% of IFE carried out on commercially available kits are difficult to interpret and thus not reportable. For identification of amyloidogenic light chain MC, sensitivity of the manual HR-IFE is 95% vs. 80% of conventional semiautomated assays. The recently introduced quantitative serum assay for immunoglobulin free light chains (FLC) is an accurate index of clonality, particularly for FLC myeloma and AL amyloidosis. To reach the highest sensitivity in MC detection a comprehensive screening panel including SPE, HR-IFE and FLC determination is recommended.

AB - Serum protein electrophoresis (SPE) is a screening test widely used in clinical practice to identify patients with monoclonal gammopathies. SPE, performed on agarose gel (AGE) or by capillary zone electrophoresis (CZE), is the only technique able to recognize a monoclonal immunoglobulin. To detect monoclonal components (MC), SPE must be visually inspected. The two available techniques show similar sensitivity for MC detection (CZE 95%, AGE 91%), with a higher specificity for AGE (99% vs. 78% for CZE). Any MC detected must be reported, because also small B-cell clones could be dangerous. Once detected, MCs need to be quantitatively measured directly on the SPE pattern by setting the limits of the corresponding peak. A concentration-related bias in MC quantitation between AGE and CZE exists. Immunotyping is the further mandatory test for confirmation and characterization of MC by either immunofixation (IFE) or immunosubtraction (ISE). In general, IFE is more sensitive than ISE, but high resolution (HRIFE) must be warranted. However, ~25% of IFE carried out on commercially available kits are difficult to interpret and thus not reportable. For identification of amyloidogenic light chain MC, sensitivity of the manual HR-IFE is 95% vs. 80% of conventional semiautomated assays. The recently introduced quantitative serum assay for immunoglobulin free light chains (FLC) is an accurate index of clonality, particularly for FLC myeloma and AL amyloidosis. To reach the highest sensitivity in MC detection a comprehensive screening panel including SPE, HR-IFE and FLC determination is recommended.

UR - http://www.scopus.com/inward/record.url?scp=84862550407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862550407&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:84862550407

VL - 36

SP - 84

EP - 89

JO - Biochimica Clinica

JF - Biochimica Clinica

SN - 0393-0564

IS - 2

ER -